X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2024-11-19 | WGS | Genedx Holdings Corp. | Ryan Jason | Dir | S - Sale | $70.57 | -47,000 | 145,758 | -24% | -$3,316,880 | |||||
M | 2024-11-15 | WGS | Genedx Holdings Corp. | Icahn School of Medicine At Mount Sinai | 10% | S - Sale | $70.64 | -147,141 | 2,719,692 | -5% | -$10,393,723 | |||||
M | 2024-11-15 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale | $70.41 | -45,415 | 60,011 | -43% | -$3,197,684 | |||||
2024-11-13 | LFST | Lifestance Health Group, Inc. | Miller Lisa K | See Remarks | S - Sale | $7.45 | -10,540 | 288,994 | -4% | -$78,523 | ||||||
2024-11-12 | USPH | U S Physical Therapy Inc /nv | Harris Bernard A Jr | Dir | S - Sale | $92.95 | -2,000 | 16,726 | -11% | -$185,900 | ||||||
2024-11-08 | USPH | U S Physical Therapy Inc /nv | Ham Nancy | Dir | S - Sale | $96.72 | -1,172 | 1,112 | -51% | -$113,356 | ||||||
2024-11-08 | USPH | U S Physical Therapy Inc /nv | Reeve Graham D. | COO | S - Sale | $96.29 | -1,724 | 19,990 | -8% | -$166,004 | ||||||
2024-11-08 | USPH | U S Physical Therapy Inc /nv | Williams Eric Joseph | Co-Chief Operations Officer | S - Sale | $95.84 | -2,000 | 14,814 | -12% | -$191,680 | ||||||
2024-11-08 | USPH | U S Physical Therapy Inc /nv | Trier Clayton | Dir | S - Sale | $95.78 | -2,000 | 6,424 | -24% | -$191,560 | ||||||
2024-11-06 | INNV | Innovage Holding Corp. | Damato Nicole | GC | S - Sale | $6.54 | -1,660 | 231,614 | -1% | -$10,856 | ||||||
2024-10-31 | WGS | Genedx Holdings Corp. | Icahn School of Medicine At Mount Sinai | 10% | S - Sale | $75.00 | -865,800 | 2,866,833 | -23% | -$64,935,000 | ||||||
D | 2024-10-29 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $66.60 | -274 | 44,951 | -1% | -$18,248 | |||||
D | 2024-10-29 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $66.60 | -2,154 | 105,426 | -2% | -$143,456 | |||||
2024-10-23 | PNTG | Pennant Group, Inc. | Stringfield Joanne | Dir | S - Sale | $33.56 | -380 | 27,805 | -1% | -$12,753 | ||||||
M | 2024-09-17 | TALK | Talkspace, Inc. | Harris Ian Jiro | CFO | P - Purchase | $2.12 | +70,100 | 397,657 | +21% | +$148,566 | |||||
M | 2024-09-16 | INNV | Innovage Holding Corp. | Damato Nicole | GC | S - Sale | $5.98 | -11,893 | 233,274 | -5% | -$71,139 | |||||
D | 2024-09-16 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $37.59 | -10,501 | 103,706 | -9% | -$394,733 | |||||
D | 2024-09-16 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $37.59 | -2,635 | 44,472 | -6% | -$99,050 | |||||
M | 2024-09-12 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $0.51 | +160,000 | 77,185,438 | 0% | +$81,552 | |||||
M | 2024-09-09 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $0.54 | +240,000 | 77,025,438 | 0% | +$128,624 | |||||
D | 2024-09-10 | PRVA | Privia Health Group, Inc. | Mehrotra Parth | CEO | S - Sale+OE | $18.50 | -135,142 | 365,106 | -27% | -$2,500,127 | |||||
D | 2024-09-09 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $33.33 | -895 | 39,910 | -2% | -$29,830 | |||||
D | 2024-09-09 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $33.33 | -3,639 | 95,457 | -4% | -$121,288 | |||||
M | 2024-09-04 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $0.49 | +240,000 | 76,785,438 | 0% | +$117,544 | |||||
A | 2023-09-14 | PIII | P3 Health Partners Inc. | Chicago Pacific Founders Ugp Iii, LLC | 10% | P - Purchase | $2.52 | +90,000 | 50,115,442 | 0% | +$227,142 | |||||
D | 2024-09-03 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $31.71 | -262 | 38,343 | -1% | -$8,308 | |||||
2024-09-03 | USPH | U S Physical Therapy Inc /nv | Gilmartin Kathleen A | Dir | P - Purchase | $86.09 | +2,000 | 18,904 | +12% | +$172,180 | ||||||
D | 2024-08-27 | PNTG | Pennant Group, Inc. | Guerisoli Brent | Pres | S - Sale+OE | $34.74 | -1,418 | 81,239 | -2% | -$49,263 | |||||
2024-08-23 | LFST | Lifestance Health Group, Inc. | Varanakis Ann | Chief People Officer | S - Sale | $6.28 | -5,269 | 263,007 | -2% | -$33,089 | ||||||
2024-08-21 | USPH | U S Physical Therapy Inc /nv | Reeve Graham D. | COO | S - Sale | $82.50 | -1,724 | 21,714 | -7% | -$142,230 | ||||||
D | 2024-08-16 | SHCR | Sharecare, Inc. | Arnold Jeffrey T | Co-Founder, Exec Chair, 10% | S - Sale+OE | $1.38 | -177,085 | 10,271,049 | -2% | -$244,501 | |||||
2024-08-13 | SHCR | Sharecare, Inc. | Blalock Michael | Chief Accounting Officer | S - Sale | $1.38 | -39,000 | 160,645 | -20% | -$53,625 | ||||||
2024-08-13 | SHCR | Sharecare, Inc. | Daniel Colin | Chief Administrative Officer | S - Sale | $1.38 | -112,000 | 490,684 | -19% | -$154,000 | ||||||
2024-08-13 | SHCR | Sharecare, Inc. | Whaley Dawn | Pres, CMO | S - Sale | $1.38 | -268,000 | 2,677,584 | -9% | -$368,500 | ||||||
2024-08-13 | SHCR | Sharecare, Inc. | Ferrero Justin | Pres, CFO | S - Sale | $1.38 | -290,000 | 2,592,077 | -10% | -$398,750 | ||||||
2024-08-13 | SHCR | Sharecare, Inc. | Arnold Jeffrey T | Co-Founder, Exec Chair, 10% | S - Sale | $1.38 | -188,000 | 10,064,438 | -2% | -$258,500 | ||||||
D | 2024-07-29 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $33.54 | -2,154 | 92,550 | -2% | -$72,245 | |||||
D | 2024-07-29 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $33.54 | -274 | 37,888 | -1% | -$9,190 | |||||
2024-07-23 | PNTG | Pennant Group, Inc. | Stringfield Joanne | Dir | S - Sale | $28.00 | -380 | 25,185 | -1% | -$10,640 | ||||||
2024-05-21 | TALK | Talkspace, Inc. | Watson Katelyn | CMO | S - Sale | $2.70 | -94,018 | 475,702 | -17% | -$253,849 | ||||||
D | 2024-05-24 | PIII | P3 Health Partners Inc. | Leavitt Legacy, LLC | 10% | P - Purchase | $0.00 | +7,974,481 | 17,813,478 | +81% | +$0 | |||||
D | 2024-06-17 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $28.31 | -2,646 | 37,409 | -7% | -$74,908 | |||||
D | 2024-06-17 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $28.31 | -7,683 | 90,830 | -8% | -$217,506 | |||||
2024-06-14 | LFST | Lifestance Health Group, Inc. | Qureshi Danish J. | See Remarks | S - Sale | $5.21 | -150,000 | 10,567,961 | -1% | -$781,515 | ||||||
2024-06-12 | LFST | Lifestance Health Group, Inc. | Pardo Ryan | See Remarks | S - Sale | $5.40 | -61,508 | 3,297,959 | -2% | -$332,143 | ||||||
2024-06-11 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $5.53 | -85,093 | 4,650,571 | -2% | -$470,564 | ||||||
2024-06-11 | PRVA | Privia Health Group, Inc. | Boehler Adam | Dir | P - Purchase | $16.50 | +364 | 5,773,522 | 0% | +$6,006 | ||||||
2024-06-10 | LFST | Lifestance Health Group, Inc. | Qureshi Danish J. | See Remarks | S - Sale | $5.25 | -83,109 | 10,717,961 | -1% | -$436,322 | ||||||
D | 2024-06-10 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $24.92 | -895 | 32,858 | -3% | -$22,303 | |||||
D | 2024-06-10 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $24.92 | -2,652 | 79,763 | -3% | -$66,088 | |||||
2024-05-21 | UPHL | Uphealth, Inc. | Rey-Giraud Agnes | Dir | S - Sale | $0.60 | -13,282 | 215,528 | -6% | -$7,974 | ||||||
M | 2024-06-03 | WGS | Genedx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $21.21 | +130,000 | 3,862,697 | +3% | +$2,757,117 | |||||
D | 2024-06-03 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $20.55 | -262 | 31,291 | -1% | -$5,384 | |||||
2024-05-30 | USPH | U S Physical Therapy Inc /nv | Reading Christopher J | COB, CEO | S - Sale | $100.26 | -2,900 | 95,838 | -3% | -$290,754 | ||||||
2024-05-29 | WGS | Genedx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $21.07 | +40,000 | 3,732,697 | +1% | +$842,604 | ||||||
2024-05-29 | PRVA | Privia Health Group, Inc. | Boehler Adam | Dir | P - Purchase | $16.50 | +5,306 | 5,773,158 | 0% | +$87,549 | ||||||
2024-05-24 | AONC | American Oncology Network, Inc. | Divers Stephen | Chief Medical Officer | P - Purchase | $2.15 | +5,000 | 163,826 | +3% | +$10,750 | ||||||
2024-05-21 | AONC | American Oncology Network, Inc. | Schonherz Todd | CEO | P - Purchase | $1.87 | +5,340 | 874,799 | +1% | +$9,962 | ||||||
M | 2024-05-28 | USPH | U S Physical Therapy Inc /nv | Reading Christopher J | COB, CEO | S - Sale | $101.18 | -2,100 | 98,738 | -2% | -$212,473 | |||||
2024-05-24 | LFST | Lifestance Health Group, Inc. | Summit Partners Growth Equity Fund Ix-A, L.P. | 10% | S - Sale | $5.89 | -3,802,345 | 41,932,358 | -8% | -$22,395,812 | ||||||
2024-05-24 | LFST | Lifestance Health Group, Inc. | Summit Partners L P | Manager of GP of 10% Owner | S - Sale | $5.89 | -3,802,345 | 41,932,358 | -8% | -$22,395,812 | ||||||
2024-05-24 | LFST | Lifestance Health Group, Inc. | Crisan Jeffrey | Member of 10% Group | S - Sale | $5.89 | -1,624,638 | 17,916,554 | -8% | -$9,569,118 | ||||||
2024-05-24 | LFST | Lifestance Health Group, Inc. | Silversmith Partners I Gp, LLC | Member of 10% Group | S - Sale | $5.89 | -1,624,638 | 17,916,554 | -8% | -$9,569,118 | ||||||
2024-05-24 | LFST | Lifestance Health Group, Inc. | Black Darren M. | Dir, 10% | S - Sale | $5.89 | -3,802,345 | 41,932,358 | -8% | -$22,395,812 | ||||||
2024-05-24 | LFST | Lifestance Health Group, Inc. | Tpg Gp A, LLC | 10% | S - Sale | $5.89 | -14,573,017 | 160,711,618 | -8% | -$85,843,814 | ||||||
2024-05-24 | PRVA | Privia Health Group, Inc. | Boehler Adam | Dir | P - Purchase | $16.49 | +4,280 | 5,767,852 | 0% | +$70,577 | ||||||
M | 2024-05-23 | WGS | Genedx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $20.15 | +170,000 | 3,692,697 | +5% | +$3,424,989 | |||||
2024-05-23 | PRVA | Privia Health Group, Inc. | McCarthy Thomas A | Dir | P - Purchase | $16.37 | +10,000 | 52,611 | +23% | +$163,700 | ||||||
M | 2024-05-21 | PRVA | Privia Health Group, Inc. | Boehler Adam | Dir | P - Purchase | $16.25 | +552,436 | 5,763,572 | +11% | +$8,978,460 | |||||
2024-05-15 | USPH | U S Physical Therapy Inc /nv | Kuntz Edward L | Dir | S - Sale | $107.57 | -2,500 | 3,280 | -43% | -$268,925 | ||||||
2024-05-13 | WGS | Genedx Holdings Corp. | Casdin Capital, LLC | Dir, 10% | P - Purchase | $23.31 | +50,000 | 3,522,697 | +1% | +$1,165,295 | ||||||
2024-05-10 | USPH | U S Physical Therapy Inc /nv | Williams Eric Joseph | Co-Chief Operations Officer | S - Sale | $104.22 | -2,500 | 16,814 | -13% | -$260,550 | ||||||
2024-05-10 | USPH | U S Physical Therapy Inc /nv | Reeve Graham D. | COO | S - Sale | $105.46 | -1,724 | 23,438 | -7% | -$181,813 | ||||||
M | 2024-05-10 | LFST | Lifestance Health Group, Inc. | Cipollone Paula | See Remarks | S - Sale | $7.21 | -50,278 | 239,915 | -17% | -$362,567 | |||||
2024-05-14 | DCGO | Docgo Inc. | Burdiek Michael J | Dir | P - Purchase | $3.40 | +10,000 | 581,595 | +2% | +$34,000 | ||||||
2024-05-13 | DCGO | Docgo Inc. | Tendler Ely D | GC, Secretary | P - Purchase | $3.13 | +10,000 | 162,933 | +7% | +$31,300 | ||||||
2024-05-13 | DCGO | Docgo Inc. | Bienstock Lee | CEO | P - Purchase | $3.15 | +25,000 | 1,220,845 | +2% | +$78,750 | ||||||
2024-05-10 | PRVA | Privia Health Group, Inc. | Mountcastle David | EVP, CFO | S - Sale | $17.88 | -2,232 | 266,422 | -1% | -$39,908 | ||||||
2024-05-10 | PRVA | Privia Health Group, Inc. | Bartrum Thomas | Former EVP, General Counsel | S - Sale | $17.88 | -1,506 | 102,356 | -1% | -$26,927 | ||||||
2024-05-10 | PRVA | Privia Health Group, Inc. | Mehrotra Parth | CEO | S - Sale | $17.88 | -13,869 | 247,771 | -5% | -$247,978 | ||||||
2024-04-30 | PRVA | Privia Health Group, Inc. | Mountcastle David | EVP, CFO | S - Sale | $18.42 | -2,320 | 268,654 | -1% | -$42,734 | ||||||
2024-04-30 | PRVA | Privia Health Group, Inc. | Bartrum Thomas | Former EVP, General Counsel | S - Sale | $18.42 | -2,252 | 103,862 | -2% | -$41,482 | ||||||
2024-04-30 | PRVA | Privia Health Group, Inc. | Mehrotra Parth | CEO | S - Sale | $18.42 | -12,219 | 261,640 | -4% | -$225,074 | ||||||
2024-04-30 | PRVA | Privia Health Group, Inc. | Morris Matthew Shawn | Dir | S - Sale | $18.42 | -11,059 | 70,101 | -14% | -$203,707 | ||||||
D | 2024-04-29 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $11.04 | -6,325 | 75,869 | -8% | -$69,808 | |||||
D | 2024-04-29 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $11.04 | -1,104 | 30,836 | -3% | -$12,185 | |||||
2024-04-19 | PNTG | Pennant Group, Inc. | Stringfield Joanne | Dir | S - Sale | $19.78 | -380 | 22,565 | -2% | -$7,516 | ||||||
2024-04-01 | LFST | Lifestance Health Group, Inc. | Qureshi Danish J. | See Remarks | S - Sale | $5.93 | -12,965 | 10,801,070 | 0% | -$76,882 | ||||||
2024-04-01 | LFST | Lifestance Health Group, Inc. | Pardo Ryan | See Remarks | S - Sale | $5.93 | -9,830 | 3,359,467 | 0% | -$58,292 | ||||||
2024-04-01 | LFST | Lifestance Health Group, Inc. | Pantaleoni Pablo | Chief Digital Officer | S - Sale | $5.93 | -10,116 | 1,299,927 | -1% | -$59,988 | ||||||
2024-04-01 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $5.93 | -9,688 | 4,735,664 | 0% | -$57,450 | ||||||
2024-01-03 | LFST | Lifestance Health Group, Inc. | Cipollone Paula | See Remarks | S - Sale | $7.45 | -3,369 | 290,193 | -1% | -$25,099 | ||||||
2024-04-02 | PRVA | Privia Health Group, Inc. | Mountcastle David | EVP, CFO | S - Sale | $17.77 | -3,933 | 270,974 | -1% | -$69,889 | ||||||
2024-03-15 | LFST | Lifestance Health Group, Inc. | Burdick Kenneth A | CEO | S - Sale | $6.28 | -214,605 | 2,934,372 | -7% | -$1,347,719 | ||||||
D | 2024-03-18 | WGS | Genedx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $10.59 | -8,559 | 66,698 | -11% | -$90,661 | |||||
D | 2024-03-18 | WGS | Genedx Holdings Corp. | Saad Kareem | Chief Transformation Officer | S - Sale+OE | $10.59 | -2,008 | 29,517 | -6% | -$21,269 | |||||
D | 2024-03-18 | WGS | Genedx Holdings Corp. | Feeley Kevin | CFO | S - Sale+OE | $10.59 | -3,253 | 28,927 | -10% | -$34,455 | |||||
2024-03-14 | LFST | Lifestance Health Group, Inc. | Mullins Kevin Michael | Chief Development Officer | S - Sale | $6.33 | -44,540 | 4,745,352 | -1% | -$281,938 | ||||||
2024-03-14 | LFST | Lifestance Health Group, Inc. | Pardo Ryan | See Remarks | S - Sale | $6.33 | -39,384 | 3,369,297 | -1% | -$249,301 | ||||||
2024-03-15 | DCGO | Docgo Inc. | Katz Steven | Dir | P - Purchase | $3.64 | +13,500 | 69,534 | +24% | +$49,140 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |